An Unusual Recurrence of Signet Ring Cell Gastric Adenocarcinoma Treated by Right Hemicolectomy, Pancreaticoduodenectomy, and IVC Resection: Controversies and Dilemmas of Following Standard Treatment Pathways

We present the case of a 67-year-old male patient with a past history of previously resected T3 right adrenocortical carcinoma and T3N1 signet ring cell adenocarcinoma of the stomach who presented with recurrence of gastric cancer in the form of a large solitary mass in the right abdomen. He was tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Sodergren, Mikael, Brammer, Kirsty, Zentler-Munro, Patrick L, Cunningham, David, Mudan, Satvinder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2015
Materias:
General Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727801/
https://www.ncbi.nlm.nih.gov/pubmed/26848413
http://dx.doi.org/10.7759/cureus.424
_version_ 1782412025911050240
author Sodergren, Mikael
Brammer, Kirsty
Zentler-Munro, Patrick L
Cunningham, David
Mudan, Satvinder
author_facet Sodergren, Mikael
Brammer, Kirsty
Zentler-Munro, Patrick L
Cunningham, David
Mudan, Satvinder
author_sort Sodergren, Mikael
collection PubMed
description We present the case of a 67-year-old male patient with a past history of previously resected T3 right adrenocortical carcinoma and T3N1 signet ring cell adenocarcinoma of the stomach who presented with recurrence of gastric cancer in the form of a large solitary mass in the right abdomen. He was treated with ECX (epirubicin, cisplatin and capecitabine) chemotherapy and multivisceral resection. This recurrence pattern is the first such description in the literature, and we discuss the controversies and arguments in favour of offering surgical resection.
format Online
Article
Text
id pubmed-4727801
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-47278012016-02-04 An Unusual Recurrence of Signet Ring Cell Gastric Adenocarcinoma Treated by Right Hemicolectomy, Pancreaticoduodenectomy, and IVC Resection: Controversies and Dilemmas of Following Standard Treatment Pathways Sodergren, Mikael Brammer, Kirsty Zentler-Munro, Patrick L Cunningham, David Mudan, Satvinder Cureus General Surgery We present the case of a 67-year-old male patient with a past history of previously resected T3 right adrenocortical carcinoma and T3N1 signet ring cell adenocarcinoma of the stomach who presented with recurrence of gastric cancer in the form of a large solitary mass in the right abdomen. He was treated with ECX (epirubicin, cisplatin and capecitabine) chemotherapy and multivisceral resection. This recurrence pattern is the first such description in the literature, and we discuss the controversies and arguments in favour of offering surgical resection. Cureus 2015-12-21 /pmc/articles/PMC4727801/ /pubmed/26848413 http://dx.doi.org/10.7759/cureus.424 Text en Copyright © 2015, Sodergren et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle General Surgery
Sodergren, Mikael
Brammer, Kirsty
Zentler-Munro, Patrick L
Cunningham, David
Mudan, Satvinder
An Unusual Recurrence of Signet Ring Cell Gastric Adenocarcinoma Treated by Right Hemicolectomy, Pancreaticoduodenectomy, and IVC Resection: Controversies and Dilemmas of Following Standard Treatment Pathways
title An Unusual Recurrence of Signet Ring Cell Gastric Adenocarcinoma Treated by Right Hemicolectomy, Pancreaticoduodenectomy, and IVC Resection: Controversies and Dilemmas of Following Standard Treatment Pathways
title_full An Unusual Recurrence of Signet Ring Cell Gastric Adenocarcinoma Treated by Right Hemicolectomy, Pancreaticoduodenectomy, and IVC Resection: Controversies and Dilemmas of Following Standard Treatment Pathways
title_fullStr An Unusual Recurrence of Signet Ring Cell Gastric Adenocarcinoma Treated by Right Hemicolectomy, Pancreaticoduodenectomy, and IVC Resection: Controversies and Dilemmas of Following Standard Treatment Pathways
title_full_unstemmed An Unusual Recurrence of Signet Ring Cell Gastric Adenocarcinoma Treated by Right Hemicolectomy, Pancreaticoduodenectomy, and IVC Resection: Controversies and Dilemmas of Following Standard Treatment Pathways
title_short An Unusual Recurrence of Signet Ring Cell Gastric Adenocarcinoma Treated by Right Hemicolectomy, Pancreaticoduodenectomy, and IVC Resection: Controversies and Dilemmas of Following Standard Treatment Pathways
title_sort unusual recurrence of signet ring cell gastric adenocarcinoma treated by right hemicolectomy, pancreaticoduodenectomy, and ivc resection: controversies and dilemmas of following standard treatment pathways
topic General Surgery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727801/
https://www.ncbi.nlm.nih.gov/pubmed/26848413
http://dx.doi.org/10.7759/cureus.424
work_keys_str_mv AT sodergrenmikael anunusualrecurrenceofsignetringcellgastricadenocarcinomatreatedbyrighthemicolectomypancreaticoduodenectomyandivcresectioncontroversiesanddilemmasoffollowingstandardtreatmentpathways
AT brammerkirsty anunusualrecurrenceofsignetringcellgastricadenocarcinomatreatedbyrighthemicolectomypancreaticoduodenectomyandivcresectioncontroversiesanddilemmasoffollowingstandardtreatmentpathways
AT zentlermunropatrickl anunusualrecurrenceofsignetringcellgastricadenocarcinomatreatedbyrighthemicolectomypancreaticoduodenectomyandivcresectioncontroversiesanddilemmasoffollowingstandardtreatmentpathways
AT cunninghamdavid anunusualrecurrenceofsignetringcellgastricadenocarcinomatreatedbyrighthemicolectomypancreaticoduodenectomyandivcresectioncontroversiesanddilemmasoffollowingstandardtreatmentpathways
AT mudansatvinder anunusualrecurrenceofsignetringcellgastricadenocarcinomatreatedbyrighthemicolectomypancreaticoduodenectomyandivcresectioncontroversiesanddilemmasoffollowingstandardtreatmentpathways
AT sodergrenmikael unusualrecurrenceofsignetringcellgastricadenocarcinomatreatedbyrighthemicolectomypancreaticoduodenectomyandivcresectioncontroversiesanddilemmasoffollowingstandardtreatmentpathways
AT brammerkirsty unusualrecurrenceofsignetringcellgastricadenocarcinomatreatedbyrighthemicolectomypancreaticoduodenectomyandivcresectioncontroversiesanddilemmasoffollowingstandardtreatmentpathways
AT zentlermunropatrickl unusualrecurrenceofsignetringcellgastricadenocarcinomatreatedbyrighthemicolectomypancreaticoduodenectomyandivcresectioncontroversiesanddilemmasoffollowingstandardtreatmentpathways
AT cunninghamdavid unusualrecurrenceofsignetringcellgastricadenocarcinomatreatedbyrighthemicolectomypancreaticoduodenectomyandivcresectioncontroversiesanddilemmasoffollowingstandardtreatmentpathways
AT mudansatvinder unusualrecurrenceofsignetringcellgastricadenocarcinomatreatedbyrighthemicolectomypancreaticoduodenectomyandivcresectioncontroversiesanddilemmasoffollowingstandardtreatmentpathways

Ejemplares similares